Global Patent Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Patent Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Today many drug companies which have produced drugs with which the public is very familiar, like Plavix®, Lipitor® and Abilify®
Patent Medicine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Patent Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adult and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Patent Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Patent Medicine key companies include Pfizer Inc., Otsuka Pharmaceutical, Merck, Novartis, Sanofi-Aventis, Bristol-Myers Squibb Co. and GSK, etc. Pfizer Inc., Otsuka Pharmaceutical, Merck are top 3 players and held % share in total in 2022.
Patent Medicine can be divided into Product Patents and Process Patents, etc. Product Patents is the mainstream product in the market, accounting for % share globally in 2022.
Patent Medicine is widely used in various fields, such as Adult and Children, etc. Adult provides greatest supports to the Patent Medicine industry development. In 2022, global % share of Patent Medicine went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Patent Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

Pfizer Inc.
Otsuka Pharmaceutical
Merck
Novartis
Sanofi-Aventis
Bristol-Myers Squibb Co.
GSK
Segment by Type
Product Patents
Process Patents
Adult
Children
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Patent Medicine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Patent Medicine introduction, etc. Patent Medicine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Patent Medicine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Patent Medicine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Patent Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adult and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Patent Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Patent Medicine key companies include Pfizer Inc., Otsuka Pharmaceutical, Merck, Novartis, Sanofi-Aventis, Bristol-Myers Squibb Co. and GSK, etc. Pfizer Inc., Otsuka Pharmaceutical, Merck are top 3 players and held % share in total in 2022.
Patent Medicine can be divided into Product Patents and Process Patents, etc. Product Patents is the mainstream product in the market, accounting for % share globally in 2022.
Patent Medicine is widely used in various fields, such as Adult and Children, etc. Adult provides greatest supports to the Patent Medicine industry development. In 2022, global % share of Patent Medicine went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Patent Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

By Company
Pfizer Inc.
Otsuka Pharmaceutical
Merck
Novartis
Sanofi-Aventis
Bristol-Myers Squibb Co.
GSK
Segment by Type
Product Patents
Process Patents
Segment by Application
Adult
Children
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Patent Medicine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Patent Medicine introduction, etc. Patent Medicine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Patent Medicine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
